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Objectives: Evaluating the success of endoluminal repair of abdominal aortic aneurysms (AAAs) is frequently based on
diameter measurements and determining the presence of endoleaks. The use of three-dimensional volumetric data and
observation of morphologic changes in the aneurysm and device have been proposed to be more appropriate for
postdeployment surveillance. The purpose of this study was to analyze the long-term volumetric and morphologic data
of 161 patients who underwent endovascular AAA exclusion and to assess the utility of volume measurements for
determining successful AAA repair.
Methods: Patients with spiral computed tomography scans obtained preoperatively, within the first postoperative month,
at 6 months, and annually thereafter, were included in this analysis. Computerized interactive three-dimensional
reconstruction of each AAA scan was performed. Total aneurysm sac volume was measured at each time interval (mean
preoperative volume 169.0  78.5 mL), and the significance of volume changes was determined by mixed linear
modeling, a form of repeated measures analysis, to account for longitudinal data clustered at the individual level.
Sixty-two patients (38%) developed endoleaks at some time during follow-up—15 type I leaks, 45 type II leaks, and 2 type
III leaks. The patients with type I and type III leaks were treated with cuffs, and the type II leaks were treated either with
observation, side-branch embolization, or required open conversion.
Results: Aneurysm sac volume increased slightly at 1-month follow-up (3.3%), and then decreased steadily to 12.9%
at 5 years (P < .0001). This effect remained unchanged after controlling for the three device types used in our study
population. Patients who did not exhibit an endoleak (n  99) showed a significant decrease in aneurysm volume across
the entire follow-up duration when compared with those who did exhibit an endoleak (n 62) (P < .0001). The presence
of a 10% or greater decrease in volume at 6 months demonstrated a sensitivity of 64%, a specificity of 95%, a positive
predictive value of 95%, a negative predictive value of 62%, and an accuracy of 75% for predicting primary clinical success
defined by successful deployment of the device; freedom from aneurysm- or procedure-related death; freedom from
endoleak, rupture, migration, or device malfunction; or conversion to open repair.
Conclusions: Volumetric analysis may be used to predict successful endoluminal exclusion of AAAs. Volume regression
appears to be device-independent and should be expected in most clinically successful cases. The presence of volume
increases in the first 6 months is suspicious for an endoleak that is pressurizing the aneurysm sac and heralds the need for
closer evaluation and possible intervention. A volume decrease of 10% or greater at 6 months and continuing regression
over time is associated with successful endovascular repair. (J Vasc Surg 2003;38:1254-63.)
The advent of endovascular techniques has revolution-
ized the way surgeons approach the treatment of abdomi-
nal aortic aneurysms (AAAs). The feasibility of endoluminal
stent-graft placement with a multitude of devices has been
well documented, and newer prostheses are rapidly being
developed.1-6 What remains unclear is the optimal mecha-
nism for assessing long-term device performance and pro-
cedural success. As the main goal of endoluminal graft
repair is to prevent aneurysm rupture and its high morbid-
ity, accurate postoperative surveillance parameters need to
be defined that predict successful outcomes and detect the
complications unique to endovascular interventions.
Shrinkage of the excluded aneurysm sac combined with
freedom from endoleak are generally felt to be indicative of
depressurization and a successful repair, and most reported
series focus on sac diameter changes and the presence or
absence of endoleaks.7-12 The use of maximal sac diameter
to track postoperative changes, however, has been chal-
lenged by recent studies.13-16 Volumetric analysis has been
proposed to be more appropriate, more accurate, and more
reliable for determining three-dimensional (3-D) morpho-
logic changes after endovascular repair. This follow-up
approach relies on precise imaging modalities and high-
lights the importance of postoperative surveillance of these
patients.17
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Three-dimensional spiral computed tomography (CT)
scanning has emerged as the gold standard and most effi-
cient modality to provide the most pertinent and accurate
information of AAA morphology.17,18 Techniques to mea-
sure volumes from spiral CT data typically require dedi-
cated workstations with complex algorithms and some-
times time-consuming and tedious manual measurements,
but recently advanced imaging software has allowed for the
automation of such calculations.15,16
The purpose of this study was to measure and analyze
the long-term volumetric and morphologic data from a
single center’s series of patients undergoing endovascular
AAA repair and to assess the utility of these measurements
for determining successful AAA exclusion. Volume changes
were specifically analyzed in the presence and absence of
endoleaks, before and after secondary intervention, and in
patients with device-related morbidity.
METHODS
Patients included in this study were involved in multi-
ple prospective Food and Drug Administration–approved
US trials performed at our institution between June 1996
and June 2001. These trials included the use of the AneuRx
bifurcated prosthesis (Medtronic AVE, Santa Rosa, Calif),
Talent bifurcated prosthesis (Medtronic World Medical,
Sunrise, Fla), and Endologix bifurcated device (Endologix,
Irvine, Calif). Patients were enrolled in a protocol approved
by the Institutional Review Board of our medical center,
and signed consents were obtained for the use of the
investigational devices and the imaging surveillance proto-
cols.
Of 269 consecutively treated patients available for re-
view, 177 (66%) patients had complete data sets of spiral
CT imaging at all predeployment intervals and at least one
postdeployment interval. This cohort constituted our study
population. Spiral CT data sets included preoperative scans
obtained within 30 days of surgery (n 177), and postop-
erative scans at 1 month (n 169), 6 months (n 161), 1
year (n 152), 2 years (n 119), 3 years (n 77), 4 years
(n  38), and 5 years (n  11). Patients enrolled in the
trials who did not have available CT data at the designated
time intervals were excluded in order to enhance the accu-
racy and comparability of the data.
All CT imaging was performed with a PQ 6000 single-
detector spiral scanner (Philips Medical Systems, Best, The
Netherlands). Parameters for the acquisitions were helical/
spiral mode with settings of slice reconstruction at 2 or 3
mm, collimation 5, table speed 10 mm/s, pitch 1:1.5, and
120-kV, 230- to 250-mA tube current. Precontrast and
postcontrast acquisitions were obtained with 140 mL of
Omnipaque (VHA Plus, Princeton, NJ) solution (concen-
tration 300-mg iodine/mL) injected at a flow rate of 3
mL/sec at 300 psi. The raw data generated from the spiral
CT were then processed and reconstructed into a 3-D
interactive model with Preview software (Version 2.0;
Medical Media Systems, West Lebanon, NH).
Analyses of sequential 3-D images at each designated
time interval for each patient were performed retrospec-
tively in a blinded fashion without knowledge of individual
outcomes by a panel of two surgeons (J.T.L and I.N.A) in
conjunction with a radiologist (I.W.). The measurements
generated were not available for the decision-making and
postoperative care of the patients in the study population.
All measurements were obtained by following standardized
definitions established by the Lifeline Registry of Endovas-
cular Aneurysm Repair.19 These guidelines include 17 mea-
surements for preoperative scans and 12 measurements for
postoperative scans, which resulted in 11,733 measure-
ments among the 177 patients included in this analysis. For
the purposes of this study, we focused on total AAA vol-
ume, which was measured from the slice immediately below
the lowest renal artery (D2a) to the slice at the aortic
bifurcation (Fig 1). This volume is composed of luminal
blood flow, thrombus, calcification, stent graft, and en-
doleak, if present. Aneurysm sac diameter was obtained
after locating the maximum cross-sectional diameter, with
all measurements made in a plane perpendicular to the
centerline of the aortic lumen rather than in slices acquired
perpendicular to the body of the patient, as is the case with
conventional axial CT.17
Repeated measures analysis was performed with a
mixed linear model to account for longitudinal data clus-
tered at the individual level.20 This was done in order to
Fig 1. Interactive 3-D model based on spiral CT data demon-
strates AAA volume measurement from the slice immediately
below the lowest renal artery to the slice at the aortic bifurcation.
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appropriately assess for change in AAA volume and to
control for confounders, including the type of graft used
during surgery, the occurrence of endoleak during the
postoperative period, and, if an endoleak occurred, the type
of secondary intervention. Endoleaks were identified on
postoperative imaging surveillance with CT angiography
and classified as type I (proximal or distal attachment zone),
type II (collateral perfusion), or type III (graft disconnec-
tion).21,22 The Wilcoxon rank sum test, Kruskal-Wallis test,
or Fisher exact test was used to test for differences between
groups, where appropriate. Measurements are presented as
mean  SD, and 95% confidence intervals (CIs) are re-
ported when applicable. All data were entered into an
electronic database (Microsoft Excel; Microsoft Corpora-
tion, Redding, Wash), and statistical analyses were per-
formed with Systat 8.0 (SPSS Inc, Chicago, Ill) and SAS
Version 8.2 (SAS Institute Inc, Cary, NC).
RESULTS
The medical records of the 177 patients from our
prospectively maintained database were reviewed; patient
demographics are shown in Table I. Of these, 154 (87%)
were men, and the mean age was 74 (range, 46 to 96) years.
Over a mean follow-up time of 39 (range, 1 to 68) months,
904 spiral CT scans were performed in the 177 patients and
the 3-D models available for analysis, including 103 An-
euRx, 44 Talent, and 30 Endologix patients. Stent grafts
were successfully placed in all 177 patients with a 30-day
mortality of 3% (95% CI 1% to 7%). Mean preoperative
AAA volume was 169 78 mL (range, 64 to 539), and sac
diameter was 5.7  0.9 cm (range, 4.1 to 9.7). Table II
shows the breakdown of preoperative AAA measurements,
and only the infrarenal neck diameter (P  .02) and AAA
volume (P .0006) were statistically different between the
device cohorts.
Volume changes in all 177 patients are graphically
represented in Fig 2. After an initial mean increase of 4.6
mL, there was an 11.5-mL decrease by 6-month follow-up
(n 161) and an annual mean decrease of 7.3 mL/year out
to 5 years. When expressed more appropriately as percent
change in AAA volume (Table III), comparisons during the
follow-up intervals demonstrated significant differences in
AAA volume change at each interval, including 1 month
(3.3%, P .0001), 6 months (2.6%, P .0001), 1 year
(5.8%, P  .0001), and 5 years (12.9%, P  .0006).
Patients treated with AneuRx devices showed a 9.4%
volume decrease at 6 months, those treated with Endologix
devices showed an 8.1% decrease, and those treated with
Talent devices showed a 5.7% decrease (Fig 3). No signifi-
cant difference in volume change was found between the
devices after controlling for them in the analysis (P  .2).
Patients without endoleak had volume regression at
Table II. Preoperative AAA measurements
All patients
(n  177)
AneuRx
(n  103)
Talent
(n  44)
Endologix
(n  30)
D2a (mm)
Neck
diameter
24.3  3.6 22.9  2.6* 27.8  3.3* 23.4  3.1*
H1 (mm)
Neck
length
30.5  14.3 32.7  14.8 26.1  15.9 29.7  13.5
D3 (cm)
Max
diameter
5.7  1.0 5.7  0.9 5.5  0.8 6.1  1.2
Angle
(degrees)
37  15 36  14 37  18 39  17
Volume
(mL)
169  78 170  73* 194  98* 128  38*
*Significant difference between devices (P  .05).
Fig 2. (A) AAA volume regression over each time interval for all
177 patients (lines reflect 95% confidence intervals). (B) Mean
changes in AAA volume for 113 patients without endoleak and 64
patients with endoleak.
Table I. Patient demographics
Comorbid factors N  177 %
ASA  3 172 97
Male 154 87
Hypertension 134 76
Age  70 127 72
Smoking  10 pack-years 92 52
History of myocardial infarction 34 19
Diabetes mellitus 27 15
Chronic renal failure (creatinine  1.4) 25 14
Congestive heart failure 24 14
Unstable angina 18 10
JOURNAL OF VASCULAR SURGERY
December 20031256 Lee et al
6-month follow-up of7.6% and continued annual regres-
sion from12.9% to24.9% out to 5 years. This subset of
patients (n  99) showed a significant decrease in volume
change across the entire follow-up duration when com-
pared with those who exhibited an endoleak or required
secondary intervention (P  .0001). When the type of
device and the occurrence of endoleak were simultaneously
controlled for, these findings did not change.
Type I endoleaks occurred in 15 patients (9%) and were
repaired with 14 proximal cuffs and 1 distal cuff (Table IV).
Seven patients had their endoleaks identified and secondary
procedures performed within the first 6 months (mean 4
months). The other eight type I endoleak patients pre-
sented much later at a mean postoperative time of 35
(range, 15 to 50) months. Volume changes for early and
late type I endoleak patients are shown in Fig 4, A, which
demonstrates volume increases of 7.3% and 15.6%,
respectively, up to the time of the secondary intervention.
After the appropriate cuff was placed, the early type I
endoleak patients exhibited volume regression of 5.5% 2
years later, and the late type I endoleak patients showed a
14.7% volume decrease 1 year later (Table V).
Type II endoleaks were found in 45 patients (25%) and,
more frequently, in patients treated with AneuRx devices
(32%) versus Talent (18%) and Endologix (13%) (P .03).
Eight patients with type II endoleaks were treated with
inferior mesenteric artery (IMA) or lumbar embolization
during the follow-up period (range, 4 to 32 months). One
of these patients underwent multiple embolizations but
had persistent aneurysm enlargement and required open
conversion at 21 months.23 Volumetric analysis of the
remaining patients who underwent embolization (n  7)
revealed a volume increase of 14.2% at 6 months.
Postembolization volume changes were small (0.9%
when compared with pre-embolization volume), even 2
years after the intervention (Table V). The patients treated
with embolization had a higher incidence of IMA-lumbar
type II leaks (75%).
Table III. Mean percent change of aneurysm sac volume compared to preoperative measurement
1 month
(n  169)
6 month
(n  161)
1 year
(n  152)
2 year
(n  119)
3 year
(n  72)
4 year
(n  38)
5 year
(n  11)
All (n  177) 3.3% 2.6% 5.8% 6.7% 7.3% 7.1% 12.9%
No leak (n  115) 2.3% 7.6% 12.9% 16.7% 19.0% 16.8% 24.9%
Endoleak (n  62) 4.9% 4.9% 4.0% 4.9% 5.3% 4.9% 1.6%
Fig 3. AAA volume regression separated into patients receiving AneuRx (n  103), Talent (n  44), and Endologix
(n  30) bifurcated stent grafts.
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Thirty-four patients with type II endoleaks were fol-
lowed until spontaneous resolution, which occurred by 6
months in 23 patients (68%). These patients typically had
lumbar-lumbar or small single-channel leaks (91%), as op-
posed to IMA-lumbar leaks. Of all observed patients, there
was an increase in volume of 4.1% at the 6-month scan,
and regression of 7.1% 2 years later, without any clinical
sequelae.
Two patients with type II endoleaks experienced rup-
tures in the postoperative period (20 m and 24 m), includ-
ing one who refused to follow-up and another who refused
intervention to treat a patent accessory renal artery that was
not excluded by the stent graft.24 The four patients who
had ruptures or required open conversions had an increas-
ing AAA volume of 22.9% at 6-month follow-up and
44.7% immediately before their interventions. Figure 4, B
summarizes the volume changes for the three groups of
type II endoleaks. The volumes for those patients who had
ruptures increased significantly, whereas those who either
were observed or underwent embolization remained rela-
tively unchanged. There was no statistically significant dif-
ference between those who were observed and those who
underwent embolization (P  .1 at 6 months).
Two type III endoleaks were discovered at 16 and 24
months, occurring when there was modular disconnection
of the main body from an iliac limb, both in patients treated
with AneuRx devices. Their stent grafts were relined with
cuffs immediately after the diagnosis was made. Interest-
ingly, they showed a 30% volume decrease at 6 months
when compared with baseline, but they had a7.1% inter-
val increase in the ensuing year, and then they showed a
22.3% regression after the secondary intervention.
Finally, one patient who suffered AAA rupture and two
patients who required secondary procedures did not exhibit
endoleaks. Cuffs were placed in a patient with significant
stent-graft migration and one with a wireform fracture.25
These patients exhibited modest volume regression, and
their complications were not predictable from volumetric
analysis. In the patient who experienced a rupture without
a demonstrable endoleak, which occurred very early in our
experience, AAA volume had increased at each interval by
large amounts (10% at 6 months and 15% at 1 year),
with only modest increases in sac diameter (1.2 mm and
2.3 mm, respectively).
Analysis of sac diameter measurements for the entire
study population revealed a mean shrinkage of 0.7 mm at 6
months, 2.4 mm at 1 year, 3.3 mm at 2 years, 3.9 mm at 3
years, 4.4 mm at 4 years, and 7.4 mm at 5 years (P 
.00001) (Fig 5). No statistically significant difference was
observed between patients with and without endoleaks
after controlling for these groups (P  .2) Out of the 64
patients that either had endoleaks or required secondary
intervention, 7 patients (11%) had sac shrinkage5 mm by
diameter, with 58 patients (89%) showing sac diameter
increases or stability, 4 patients demonstrating sac shrink-
age of at least 5% by volume (6%), and 61 patients showing
sac increases or stability by volume (94%).
A 10% reduction in volume at 6 months identified
primary clinical success (defined as successful deployment
of the endovascular device and freedom from procedure- or
device-related death, endoleak, rupture, conversion, migra-
tion, device failure, or need for secondary intervention26)
with a sensitivity of 64%, a specificity of 95%, a positive
predictive value of 95%, and an accuracy of 75%. Similar
analyses were performed with two-dimensional diameter
decreases of 5 mm at both 6-month and 1-year postop-
erative intervals, and the results are summarized in Table
VI.
Table IV. Endoleaks, secondary procedures, and mortality
Complication (%) Device
No. of
patients (%) Treatment/Outcome
Early Type I endoleak (4%) AneuRx n  1 (1%) Proximal cuff 6 m
Talent n  3 (7%) Proximal cuff 1 w, 3 m, 7 m
Endologix n  3 (10%) Proximal cuff 2 m, 2 m, 7 m
Late Type I endoleak (5%) AneuRx n  6 (6%) Distal cuff 24 m, Proximal cuff 31 m,
40 m, 46 m, 48 m, 50 m
Talent n  1 (2%) Proximal cuff 28 m
Endologix n  1 (3%) Proximal cuff 15 m
Type II endoleak (25%) AneuRx n  33 (32%) Observation (n  23)
Embolization (n  6)
Rupture/conversion (n  2)
Open conversion (n  2)
Talent n  8 (18%) Observation (n  7)
Embolization (n  1)
Endologix n  4 (13%) Observation (n  4)
Type III endoleak (1%) AneuRx n  2 (2%) Modular dislocation (cuff 16 m, 24 m)
Secondary procedure without endoleak (2%) AneuRx n  1 (1%) Rupture (26 m)
Talent n  2 (5%) Migration (cuff 25 m)
Wireform fracture (cuff 19 m)
30-day mortality (3%) AneuRx n  1 (1%) Rupture
Talent n  3 (7%) Ischemic bowel (n  2)
Myocardial infarction
Endologix n  1 (3%) Myocardial infarction
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DISCUSSION
As more experience is gained with endovascular tech-
niques, the technical aspects of endoluminal AAA repair are
being refined to afford patients better outcomes. The high
“success” rate of many series in the literature point out that
AAA exclusion with a particular device is able to be per-
formed usually in over 90% of patients it is attempted in,
and with certain advantages in high-risk patients when
compared with conventional open repair.27,28 We now
should shift the focus to long-term surveillance and define
objective parameters that measure the efficacy of endovas-
cular interventions. This need highlights the renewed in-
terest in studying aneurysm morphology and the develop-
ment of sophisticated software to analyze data generated by
Fig 4. A, Changes in total AAA volume over time of seven patients early Type I endoleak (mean postoperative time
4 m) and eight patients with late Type II endoleak (mean postoperative time  35 m). All patients were treated with
the appropriate cuff (shown as arrows). B, Changes in total AAA volume over time of Type II endoleak patients treated
with observation (n 33), embolization (n 7), or open conversion/rupture (n 5). Embolization occurred at mean
postoperative time of 8 months (shown by arrow).
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newer imaging methods such as spiral CT, magnetic reso-
nance 3-D imaging, and 3-D ultrasound scanning.17,18,29
Numerous early reports on aneurysm morphology after
endovascular repair consisted of studies focusing on sac
diameter regression in patients without demonstrable peri-
graft flow and on an increase in size in those patients with
endoleak.8-12 There have been, however, reports of aneu-
rysm shrinkage in the face of endoleaks and aneurysm
expansion in the absence of endoleaks, all based on diame-
ter measurements.30 The concept of simple two-dimen-
sional data to predict AAA wall stress and subsequent risk of
rupture has been recently questioned, and more detailed
3-D modeling and measurements have been proposed to
be more predictive.31,32
Balm et al33 first suggested that changes in volume
might be more appropriate to discriminate successful from
failed exclusion in a small report of nine patients with AAA
sac and volume regression occurring in seven successfully
excluded aneurysms at 6-month follow-up. Diameter mea-
surements were found by Wever et al13 not to reflect actual
size changes when compared with volume measurements in
37% of cases, and they proposed volume criteria to more
reliably discern subtle morphologic changes at an earlier
time. Our study substantiates this finding, because discor-
dance was found between sac diameter measurements and
volume changes at the 6-month interval in 31% of cases.
Other recent reports have documented or attempted to
classify aneurysm sac volumetric changes in small series (30
to 50 patients) after stent-graft repair, usually with mixed
aortouniiliac and bifurcated devices, as well as thoracic
grafts.14-16
This current study includes a significant number of
patients at longer follow-up intervals with comparable CT
data and evaluates the usefulness of volume criteria in the
long-term surveillance after endovascular repair. In our
study, significant mean volume regression was found at 6
months, with continuing volume decreases out to 5 years.
Annual regression rates were 7.3 mL/year for the entire
cohort and 11.5 mL/year for those without demonstrable
endoleak, and these findings agree with others’ experienc-
es.14-16,34,35 Because the three devices used in this study
population all had different mean preoperative volumes,
percent volume changes were the focus of this analysis.
The effect of device type on volume regression was
found not to be significant across the entire follow-up
period (P  .2) and after controlling for the presence or
absence of endoleak (P  .3). This implies that volume
regression was device-independent in this series. Because
we preferentially use self-expanding, fully stent-lined de-
vices, these findings cannot be translated to stent grafts that
use other means of fixation or have unsupported compo-
nents. The volume regression patterns reported here need
to be compared with other series where different devices
were used.
The definition of successful endovascular repair is also a
topic of debate. Acute parameters are those that led to the
initial approval of this technology, namely, comparable
mortality, decreased morbidity, and shorter hospital stay
and disability, and they have continued to be observed over
time.36 We currently base clinical success on successful
technical deployment; freedom from procedure- or device-
related death, rupture, endoleak, migration, conversion,
and secondary intervention; and aneurysm shrinkage by
volumetric measurements.26 In our study population, 64
patients had either endoleaks or needed a secondary inter-
vention, and only 2 showed significant volume regression
on 6-month CT. This finding allowed us to establish the
criterion of 10% or greater volume regression at 6 months
as a useful predictor for long-term clinical success. Com-
parisons with sac diameter changes (Table VI) confirm that
volume criteria are more sensitive and accurate in predict-
ing primary clinical success at an equivalent or earlier time
interval.
Lack of volume regression is caused by continued pres-
surization within the sac, most often due to endoleaks.
Type I endoleaks interestingly occurred at two peaks,
within the first 6 months and at 35 months. In retrospect,
all 15 patients with type I endoleaks were identified by
gradually increasing volumes, and in the 8 patients with
type I endoleaks that presented late, suspicion should have
been raised because of lack of volume regression. After the
appropriate cuff was placed, there were significant volume
decreases of 5.5% to 14.7% in the year after the second
Table V. Volume regression patterns for endoleak types
Endoleak
Time course/
treatment n  64
Pre-
intervention*
Post-
intervention
†
Type I Early 7 7.3% 5.5%
Late 8 14.6% 14.7%
Type II Embolization 7 19.5% 0.9%
Observation 34 4.1% 7.1%
Rupture/
conversion
4 44.7% n/a
Type III Late 2 7.1% 22.3%
*Compares the preoperative scan to the scan immediately before the inter-
vention.
†
Compares the scan immediately before the intervention to the scan 2 years
postintervention (or sooner if not available).
Fig 5. Maximal sac diameter changes for all 177 patients; sepa-
rated by the presence or absence of endoleak.
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intervention, which indicates assisted primary clinical suc-
cess. The occurrence of late type I endoleaks further high-
lights the need for long-term follow-up for all endograft
patients.
The optimal treatment for type II endoleaks, when
there is retrograde flow into the aneurysm sac through
lumbar, IMA, or small side branch vessels, is unclear.37 In
our experience, there were three distinct patterns of volume
regression based on treatment of the leak (Fig 4, A). Of the
34 patients that were observed without long-term sequelae,
there was an increase in volume at 6-month follow-up, but
then regression of7.1% by 2 years. This suggests that type
II endoleaks with AAA volume regression after 6 months
are probably of insignificant origin, and they can be safely
observed. Most of these patients had single-channel or
lumbar-lumbar endoleaks (91%), as opposed to the more
significant IMA-lumbar leaks.
A more substantial volume increase (19.5%) was seen in
the seven patients who underwent successful embolization
at 6-month follow-up, and this rate of expansion was
slowed 2 years after embolization (0.9%). Significant
volume regression was therefore not seen postintervention.
This finding does not agree with the series of seven success-
fully treated type II endoleaks with embolization, where
significant sac regression was noted as measured by maxi-
mal aneurysm cross-sectional area.38 This again might
point out the inadequacies of two-dimensional criteria for
the follow-up of patients. Another explanation is that our
seven patients who underwent embolization are still under
the influences of endotension that is retarding aneurysm
volume regression. Still another possibility is that the em-
bolization is not the optimal treatment for these patients or
that the intervention was not performed early enough.
Again, continued postoperative surveillance is mandatory
to fully understand the consequences of all types of second-
ary interventions.
The most substantial volumetric changes occurred in
the four patients with type II endoleaks who suffered
ruptures or open conversion. Figure 4, B shows the large
volume increases (44.7% at time of rupture) up until the
time of complication. The outcomes were predictable be-
cause of continued volume expansion, which occurred in
two patients who refused treatment or follow-up and in two
patients treated early in our experience prior to having
volume measurements available for clinical decision mak-
ing.
We had only two type III endoleaks, both occurring
late, and after significant volume regression at 6-month
(30.4%) and 1-year (27.4%) follow-up. The discovery
of the modular disconnection was correlated with a modest
increase in volume in the interval leading up to the second-
ary intervention (7.1%), and then after the cuff was
placed, there was continued volume regression 1 year later
(22.3%). This pattern of a late increase after initial signif-
icant regression is in agreement with Pollock et al,16 who
found only one type III endoleak in their series of 50
patients. One possibility is that a rapid volume decrease in
the first 6 months led to morphologic changes and forces
that caused graft instability and subsequent modular dis-
connection. As more bifurcated grafts are placed, we will
undoubtedly be faced with discovering the optimal treat-
ment and identification of type III endoleaks.
This assessment of the value and accuracy of volumetric
analysis has modified our clinical practice. We aggressively
identify and treat any type I or type III endoleaks with cuffs.
Type II endoleaks when identified can be safely observed if
the leak is from a single-channel or lumbar-lumbar connec-
tion and if the AAA volume is not significantly increasing. If
there is an increase in AAA volume or the leak consists of an
IMA-lumbar connection, then embolization is attempted.
If successful, we expect no further AAA enlargement. In the
face of an expanding AAA volume without demonstrable
endoleak, we have adopted the policy of provocative tests
to search out an endoleak or cause, including obtaining
more frequent spiral CT scans, angiography, magnetic res-
onance angiograms, or intravascular ultrasound scans.
Our study is limited by its retrospective design. Al-
though review of the imaging data was performed retro-
spectively, we attempted to minimize misclassification bias
by blinding the reviewers to patient outcome. Selection
bias was minimized because we used a mixed linear model
to analyze volume changes over time. This form of analysis
is designed, in part, to account for the unbalanced data.
Thus, no missing longitudinal measurements (ie, CT scans)
were excluded.
The issue of intraobserver and interobserver variability
has also been raised when evaluating spiral CT data. In-
traobserver variability has been found to be smaller than
interobserver variability, implying that measurements and
trends in the postoperative follow-up will be more accurate
if performed by one observer or panel.39 Another study
pointed out that differences between manual measure-
ments with calipers and computerized measurements ex-
ceed 2 to 3 mm, and that automated observer-independent
measuring techniques should be used.40 For those reasons,
we used a computerized 3-D reconstruction and made our
Table VI. Predictive accuracies of volume change (at 6 months) versus sac diameter changes (at 6 months and 1 year)
for primary clinical success (with 95% confidence intervals)
Sensitivity Specificity Accuracy
Positive
predictive value
Negative
predictive value
Volume regression  10% at 6m 64% (49%–70%) 95% (87%–99%) 75% (67%–81%) 95% (86%–99%) 62% (52%–72%)
Sac regression  5mm at 6m 9% (4%–16%) 91% (81%–97%) 41% (33%–49%) 60% (32%–84%) 39% (31%–47%)
Sac regression 5mm at 1 y 37% (27%–48%) 83% (72%–91%) 56% (48%–64%) 75% (60%–87%) 49% (39%–58%)
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measurements as a group with both vascular surgeons and
radiologists. We have noted intraobserver variability of
approximately 2% to 3%, which is in agreement with other
studies.41,42
In conclusion, we believe that volumetric analysis is a
necessary and accurate adjunct in the follow-up after en-
doluminal exclusion of AAAs and can be used to assess
primary clinical success. AAA sac volume increases occur
with perigraft flow and an aneurysm that is still at risk for
rupture, which heralds the need for closer evaluation and
surveillance and possible intervention. Volume changes are
more predictive than are traditional sac diameter measure-
ments for determining successful exclusion and detecting
potential problems. A volume decrease of 10% or greater at
6 months and continuing regression over time is associated
with successful endovascular repair and protection from
rupture.
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